StonvexLoading…
StonvexStonvexStonvexCore line items from PRLD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $4.58M | $12.14M | $6.50M | $0.00 |
Operating Income | $-14.18M | $-104.57M | $-87.22M | $-34.61M |
Net Income | $-10.38M | $-99.50M | $-83.04M | $-32.09M |
EPS (Diluted) | $-0.13 | $-1.29 | $-1.09 | $-0.42 |
Total Assets | $119.64M | $141.31M | $94.75M | $141.26M |
Total Liabilities | $59.46M | $72.68M | $36.22M | $38.08M |
Cash & Equivalents | $21.76M | $35.26M | $47.53M | $40.27M |
Free Cash Flow OCF − CapEx | $-21.68M | $-56.37M | $-79.49M | $-34.28M |
Shares Outstanding | 82.52M | 76.96M | 76.04M | 75.99M |